Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$20.58
$7.34
$29.25
$108.83M0.8477,920 shs562,700 shs
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
$0.04
$0.04
$0.01
$0.20
$28.18M2.991.60 million shsN/A
RYSMF
Royal Standard Minerals
$0.00
$0.00
$0.00
$0.00
N/A0.34N/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
$5.75
-1.4%
$4.66
$2.92
$7.06
$53.65M1.3778,138 shs115,122 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
0.00%0.00%0.00%0.00%0.00%
RYSMF
Royal Standard Minerals
0.00%0.00%0.00%0.00%-98.00%
U.S. Gold Corp. stock logo
USAU
U.S. Gold
0.00%-1.85%+34.02%+62.40%+34.95%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
N/AN/AN/AN/AN/AN/AN/AN/A
RYSMF
Royal Standard Minerals
N/AN/AN/AN/AN/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
2.9507 of 5 stars
3.55.00.00.03.22.50.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/A
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
N/AN/AN/AN/A
RYSMF
Royal Standard Minerals
N/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
3.00
Buy$14.50152.17% Upside

Current Analyst Ratings

Latest QTMM, USAU, RYSMF, and OPNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/3/2024
U.S. Gold Corp. stock logo
USAU
U.S. Gold
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
(Data available from 6/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$47.78M0.00N/A24.75$9.92 per share0.00
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
N/AN/AN/AN/AN/AN/A
RYSMF
Royal Standard Minerals
N/AN/AN/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/AN/AN/AN/A$2.24 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$3.01M-$6.56N/AN/AN/A-147.90%-97.03%-59.66%N/A
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
-$8.96MN/A0.00N/AN/AN/AN/AN/A
RYSMF
Royal Standard Minerals
-$70K-$0.05N/AN/AN/AN/A-1,112.56%N/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
-$7.61M-$0.73N/AN/AN/A-40.73%-31.42%7/29/2024 (Estimated)

Latest QTMM, USAU, RYSMF, and OPNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q3 2024
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/A-$0.18-$0.18-$0.18N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/AN/A
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
N/AN/AN/AN/AN/A
RYSMF
Royal Standard Minerals
N/AN/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
0.60
5.48
5.48
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
N/AN/AN/A
RYSMF
Royal Standard Minerals
N/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/A
10.49
10.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
42.39%
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
0.08%
RYSMF
Royal Standard Minerals
N/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
6.64%

Insider Ownership

CompanyInsider Ownership
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
25.15%
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
12.78%
RYSMF
Royal Standard Minerals
N/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
12.59%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
375.27 million3.87 millionNot Optionable
Quantum Materials Corp. stock logo
QTMM
Quantum Materials
27704.57 millionN/ANot Optionable
RYSMF
Royal Standard Minerals
N/AN/AN/ANot Optionable
U.S. Gold Corp. stock logo
USAU
U.S. Gold
49.33 million8.16 millionOptionable

QTMM, USAU, RYSMF, and OPNT Headlines

Recent News About These Companies

HC Wainwright Reaffirms Buy Rating for U.S. Gold (NASDAQ:USAU)
Gold And U.S. Politics
US Gold to update CK PFS, FS and financing

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Opiant Pharmaceuticals logo

Opiant Pharmaceuticals

NASDAQ:OPNT
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
Quantum Materials logo

Quantum Materials

OTCMKTS:QTMM
Quantum Materials Corp. engages in the design, development, production and supply of nanomaterials, including quantum dots, tetrapod quantum dots, and other nanoparticles for a range of applications in televisions, displays and other optoelectronics, photovoltaics, solid state lighting, life sciences, security ink, battery, and sensor sectors of the market. The company was founded by Stephen Squires on January 9, 2007 and is headquartered in San Marcos, TX.

Royal Standard Minerals

OTCMKTS:RYSMF
Royal Standard Minerals Inc. does not have significant operations. The company focuses on identify, acquire, or merge with assets or businesses. Previously, it was engaged in the acquisition, exploration, and development of gold and precious metal properties. Royal Standard Minerals Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
U.S. Gold logo

U.S. Gold

NASDAQ:USAU
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 601 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 77 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project located in Eureka County, Nevada. The company was formerly known as Dataram Corporation and changed its name to U.S. Gold Corp. in June 2017. U.S. Gold Corp. is based in Elko, Nevada.